| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.32B | 89.79B | 83.76B | 83.98B | 75.50B | 73.12B |
| Gross Profit | 17.96B | 17.27B | 14.90B | 15.13B | 14.69B | 12.27B |
| EBITDA | 9.74B | 8.98B | 7.04B | 6.81B | 6.57B | 4.77B |
| Net Income | 6.43B | 5.91B | 4.80B | 4.64B | 4.37B | 3.08B |
Balance Sheet | ||||||
| Total Assets | 91.29B | 99.92B | 98.23B | 94.69B | 87.47B | 86.14B |
| Cash, Cash Equivalents and Short-Term Investments | 30.53B | 26.77B | 31.95B | 29.93B | 33.96B | 34.90B |
| Total Debt | 2.13B | 17.00M | 7.00M | 13.00M | 21.00M | 15.00M |
| Total Liabilities | 20.05B | 28.23B | 28.31B | 29.97B | 24.05B | 23.54B |
| Stockholders Equity | 70.22B | 70.68B | 68.92B | 63.75B | 61.99B | 61.23B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -847.00M | 3.92B | 911.00M | 1.60B | 10.73B |
| Operating Cash Flow | 0.00 | -616.00M | 4.17B | 1.12B | 1.70B | 10.77B |
| Investing Cash Flow | 0.00 | -1.79B | 244.00M | -2.55B | -269.00M | 172.00M |
| Financing Cash Flow | 0.00 | -3.77B | -3.38B | -3.60B | -2.87B | -1.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥146.65B | 9.06 | ― | 3.22% | 12.23% | 43.29% | |
79 Outperform | ¥93.65B | 15.89 | ― | 3.63% | 35.73% | 62.37% | |
76 Outperform | ¥95.50B | 13.41 | ― | 4.38% | -0.84% | -1.80% | |
69 Neutral | ¥115.46B | 11.04 | ― | 2.81% | -3.99% | 13.29% | |
68 Neutral | ¥127.39B | 11.19 | ― | 2.14% | 4.81% | -1.16% | |
64 Neutral | ¥116.88B | 13.33 | ― | 2.13% | 7.22% | 21.92% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |